TP53 and cancer: This luminal-to-basal transition is thought to be critical for cancer progression, as it promotes stemness and invasiveness of BRCA1- or p53-mutant mammary epithelial cells in vitro (Bai et al., 2022; Kim et al., 2011; Liu et al., 2008; Mizuno et al., 2010).